EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers

Prerna Dabral iD, Nobel Bhasin, Manish Ranjan iD, Maysoon M Makhlouf, Zakaria Y Abd Elmageed iD

Cancers · 05.07.2024 · 16 (13) · 2462

DOI: 10.3390/cancers16132462 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 05.07.2024. Verfasst von Prerna Dabral und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant Research Institute, University of California San Francisco, San Francisco, CA 94105, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edwaed Via College of Osteopathic Medicine, VCOM/Delta Collaboration Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early cancer detection and accurate monitoring are crucial to ensure increased patient survival. Recent research has focused on developing non-invasive biomarkers to diagnose cancer early and monitor disease progression at low cost and risk. Extracellular vesicles (EVs), nanosized particles secreted into extracellular spaces by most cell types, are gaining immense popularity as novel biomarker candidates for liquid cancer biopsy, as they can transport bioactive cargo to distant sites and facilitate intercellular communications. A literature search was conducted to discuss the current approaches for EV isolation and the advances in using EV-associated proteins, miRNA, mRNA, DNA, and lipids as liquid biopsies. We discussed the advantages and challenges of using these vesicles in clinical applications. Moreover, recent advancements in machine learning as a novel tool for tumor marker discovery are also highlighted.

Schlagwörter

Stichwörter der Autor:innen

cargo moleculesextracellular vesiclesisolationliquid biopsytumor biomarkers

Autor:innen und Institutionen

  • Vitalant Research Institute, University of California San Francisco, San Francisco, CA 94105, USA.
  • Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Biomedical Sciences, Discipline of Pharmacology, Edward Via College of Osteopathic Medicine (VCOM), 4408 Bon Aire Drive, Monroe, LA 71203, USA.

ORCID-Profile: Prerna Dabral, Manish Ranjan, Zakaria Y Abd Elmageed

Förderung

  • Edwaed Via College of Osteopathic Medicine
  • VCOM/Delta Collaboration Research Program

Zitieren

APA

Dabral, P., Bhasin, N., Ranjan, M., Makhlouf, M. M., & Abd Elmageed, Z. Y. (2024). Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers. Cancers, 16(13), 2462. https://doi.org/10.3390/cancers16132462

Vancouver

Dabral P, Bhasin N, Ranjan M, Makhlouf MM, Abd Elmageed ZY. Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers. Cancers. 2024;16(13):2462. doi:10.3390/cancers16132462

BibTeX
@article{Dabral2024,
  author = {Dabral, Prerna and Bhasin, Nobel and Ranjan, Manish and Makhlouf, Maysoon M and Abd Elmageed, Zakaria Y},
  title = {Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {13},
  pages = {2462},
  doi = {10.3390/cancers16132462}
}
Kostenlos starten →